Long-term liabilities 20,208 2,684
Stockholders' equity 105,919 90,782
$146,402 $107,960
NUTRACEUTICAL INTERNATIONAL CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited; dollars in thousands, except per share data)
Three months ended Twelve months ended
September 30, September 30,
2007 2006 2007 2006
Net sales $39,902 $35,691 $156,548 $150,405
Cost of sales 18,429 16,945 71,622 71,191
Gross profit 21,473 18,746 84,926 79,214
Operating expenses
Selling, general and
administrative 16,217 13,582 61,905 55,389
Amortization of
intangible assets 161 9 391 289
Impairment of
intangible asset 450 - 450 -
Income from operations 4,645 5,155 22,180 23,536
Interest and other
(income)/expense, net 443 136 1,257 (757)
Income before provision
for income taxes 4,202 5,019 20,923 24,293
Provision for income taxes 1,597 1,933 7,951 9,353
Net income $2,605 $3,086 $12,972 $14,940
Net income per common
share
Basic $0.23 $0.28 $1.17 $1.32
Diluted 0.23 0.27 1.15 1.30
Weighted average common
shares outstanding
'/>"/>| SOURCE Nutraceutical International Corporation Copyright©2007 PR Newswire. All rights reserved |